| Basics |
Alkermes plc Ordinary Shares
Alkermes PLC is a fully integrated, biopharmaceutical company. It applies its scientific expertise and proprietary technologies to research, develop and commercialize pharmaceutical products to address unmet medical needs of patients.
|
| IPO Date: |
August 1, 1991 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$4.94B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.49 | 1.86%
|
| Avg Daily Range (30 D): |
$0.38 | 1.36%
|
| Avg Daily Range (90 D): |
$0.41 | 1.39%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.07M |
| Avg Daily Volume (30 D): |
1.36M |
| Avg Daily Volume (90 D): |
1.33M |
| Trade Size |
| Avg Trade Size (Sh.): |
118 |
| Avg Trade Size (Sh.) (30 D): |
56 |
| Avg Trade Size (Sh.) (90 D): |
58 |
| Institutional Trades |
| Total Inst.Trades: |
13,557 |
| Avg Inst. Trade: |
$2.53M |
| Avg Inst. Trade (30 D): |
$2.97M |
| Avg Inst. Trade (90 D): |
$3.83M |
| Avg Inst. Trade Volume: |
.09M |
| Avg Inst. Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.2M |
| Avg Closing Trade (30 D): |
$7.29M |
| Avg Closing Trade (90 D): |
$9.05M |
| Avg Closing Volume: |
176.21K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$2.14
|
$.53
|
$.14
|
|
Diluted EPS
|
$2.07
|
$.52
|
$.13
|
|
Revenue
|
$ 1.51B
|
$ 390.66M
|
$ 306.51M
|
|
Gross Profit
|
$ 1.28B
|
$ 341.2M
|
$ 257.31M
|
|
Net Income / Loss
|
$ 348.45M
|
$ 87.1M
|
$ 22.46M
|
|
Operating Income / Loss
|
$ 374.21M
|
$ 92.98M
|
$ 13.79M
|
|
Cost of Revenue
|
$ 223.87M
|
$ 49.46M
|
$ 49.2M
|
|
Net Cash Flow
|
$ -13.95M
|
$ 121.39M
|
$ 108.66M
|
|
PE Ratio
|
14.46
|
|
|
|
|
|
